PEGylated interferon beta 1a

Related by string. * Pegylated . pegylated : pegylated interferon ribavirin . telaprevir pegylated interferon . pegylated interferon alpha / Interferon . interferons . Interferons : PEG Interferon lambda . Topical Interferon Alpha 2b . interferon beta 1a / BETA . betas . Betas : Pi Beta Phi . Zeta Phi Beta Sorority . Beta Theta Pi / 1As . 1as . 1AD : Item 1A Risk Factors . II Item 1A * *

Related by context. Frequent words. (Click for all words.) 69 relapsing remitting multiple sclerosis 69 Pivotal Phase III 68 tocilizumab 68 Pivotal Phase 68 nab paclitaxel 67 6R BH4 67 relapsed refractory multiple myeloma 66 Chronic Hepatitis C 66 pertuzumab 66 CR# vcMMAE 66 Amrubicin 66 vandetanib 66 Monotherapy 66 TORISEL 66 DOXIL 66 orally bioavailable 66 RRMS 66 thromboembolic events 66 Carfilzomib 66 axitinib 66 RRMS patients 66 mycophenolate mofetil 65 Irinotecan 65 Alemtuzumab 65 hypercalcemia 65 Torisel 65 Completes Enrollment 65 Laquinimod 65 metastatic hormone refractory 65 rNAPc2 65 PXD# 65 Phase III Clinical Trial 65 Apixaban 65 Voreloxin 65 glatiramer acetate 65 refractory multiple myeloma 65 HER2 positive metastatic breast 65 tanespimycin 65 Clinical Trial Results 65 ocrelizumab 65 administered subcutaneously 65 DAVANAT 65 Pivotal Trial 65 diabetic neuropathic pain 65 LY# [003] 65 Chronic Lymphocytic Leukemia 65 lymphoma CTCL 65 temsirolimus 65 REMICADE ® 65 romidepsin 64 Allovectin 7 R 64 decitabine 64 Phase III Trial 64 Cethromycin 64 tumor lysis syndrome 64 mg QD 64 laquinimod 64 Bevacizumab 64 Patients Treated 64 lupus nephritis 64 eltrombopag 64 COPD exacerbations 64 Trastuzumab 64 Ofatumumab 64 PROMACTA 64 Phenoptin 64 LymphoStat B 64 BAY #-# 64 Fidaxomicin 64 TAXUS Stent 64 Drug Candidate 64 registrational trial 64 TYKERB 64 Initiates Phase 64 secondary hyperparathyroidism 64 Gabapentin GR 63 Lenalidomide 63 SCH # 63 metastatic renal cell carcinoma 63 Phase 1b trial 63 Bortezomib 63 NOXAFIL 63 humanized anti 63 Pirfenidone 63 Navelbine 63 Ischemic 63 relapsing MS 63 mg BID 63 phase IIa 63 Azixa 63 CA4P 63 ADHF 63 relapsed multiple myeloma 63 Pharmacokinetic 63 adalimumab 63 romiplostim 63 Azedra 63 plus gemcitabine 63 dose cohorts 63 Heart Failure Patients 63 CMV disease

Back to home page